# Olanzapine and Fluoxetine

NDC: 0093-5504
Generic name: Olanzapine and Fluoxetine
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20120619

FDA application: ANDA077528

## Active ingredients

- FLUOXETINE HYDROCHLORIDE: 25 mg/1
- OLANZAPINE: 6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-5504"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-5504
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c28cf18-01a3-468a-ab3e-8aa82f918251